| Schedule of Basic and Diluted Net Income Per Share |
Basic and diluted net income (loss) per share were calculated as follows for the periods presented (in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator: | | | | | | | | | | Net Income (Loss) | | $ | 41,726 | | | (29,492) | | | $ | 112,758 | | | $ | (36,844) | | | Plus: Return on Share Purchase and Forfeiture | | — | | | — | | | 355 | | | — | | | Less: Net Income Allocated to Participating Securities | | (34,192) | | | — | | | (89,041) | | | — | | | Net Income (Loss) Attributable to Common Stockholders | | $ | 7,534 | | | $ | (29,492) | | | $ | 24,072 | | | $ | (36,844) | | | Denominator: | | | | | | | | | | Weighted average shares used in computing basic net income (loss) per share | | 79,691,819 | | | 78,029,045 | | | 78,960,756 | | | 77,746,658 | | | Effect of dilutive securities: | | | | | | | | | | Stock options | | 47,399,002 | | | — | | | 50,110,233 | | | — | | | Common stock warrants | | — | | | — | | | 246,951 | | | — | | | Convertible preferred stock warrants | | 604,868 | | | — | | | 70,399,822 | | | — | | | Weighted-average shares used in computing diluted net income (loss) per share | | 127,695,689 | | | 78,029,045 | | | 199,717,762 | | | 77,746,658 | | | Net Income (Loss) Per Share – Basic | | $ | 0.09 | | | $ | (0.38) | | | $ | 0.30 | | | $ | (0.47) | | | Net Income (Loss) Per Share – Diluted | | $ | 0.06 | | | $ | (0.38) | | | $ | 0.12 | | | $ | (0.47) | |
|
| Schedule of Dilutive Shares Excluded from the Diluted Net Income (Loss) Per Share Calculation |
The following common stock equivalents were excluded from the computation of diluted net income (loss) per share for the periods presented because including them would have been anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2026 | | 2025 | | 2026 | 2025 | | | (shares) | | (shares) | | (shares) | (shares) | | Excluded securities: | | | | | | | | | Convertible preferred stock issued and outstanding, excluding shares held by consolidated VIE | | 370,622,512 | | | 209,979,779 | | | 301,035,432 | | 209,979,779 | | | Stock options issued and outstanding | | 25,893,512 | | | 76,965,892 | | | 25,643,692 | | 78,624,614 | | | Common stock warrants issued and outstanding | | — | | | 705,349 | | | 52,758 | | 705,349 | | | Series E-1 convertible preferred stock warrants | | — | | | 35,544,141 | | | — | | 35,544,141 | | | Series F convertible preferred stock warrants | | — | | | 126,106,580 | | | — | | 126,106,580 | | Total common stock equivalents excluded from diluted net income (loss) per common share computation | | 396,516,024 | | | 449,301,741 | | | 326,731,882 | | 450,960,463 | |
|